J. A. Shabbits

Tumor chemosensitization strategies based on apoptosis manipulations.

J. A. Shabbits, Yanping Hu, L. Mayer, 2003, Molecular cancer therapeutics.

The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug Resistance

J. A. Shabbits, L. Mayer, 2004, Cancer and Metastasis Reviews.

A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131.

K. Gelmon, D. Ayers, L. Seymour, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Molecular and pharmacological strategies to overcome multidrug resistance

J. A. Shabbits, L. Mayer, R. Krishna, 2001, Expert review of anticancer therapy.

Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems.

J. A. Shabbits, L. Mayer, G. Chiu, 2002, Journal of controlled release : official journal of the Controlled Release Society.

P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.

J. A. Shabbits, L. Mayer, 2002, Molecular cancer therapeutics.

Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro.

J. A. Shabbits, L. Mayer, 2003, Biochimica et biophysica acta.

Therapeutic applications of ceramide lipids for apoptosis induction

J. A. Shabbits, 2003 .

Integrin-linked kinase (ILK) in combination molecular targeting.

S. Dedhar, M. Bally, J. A. Shabbits, 2004, Cancer treatment and research.